The Life Sciences Law Review - 5th edition

The fifth edition of the Life Sciences Law Review provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in 37 jurisdictions. Sophie Pelé, Paris national partner, wrote the French chapter which contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

This overview will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in the French market.